The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment
about
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.Management of antipsychotic-related weight gainPharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for cliniciansPolymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetesGenetics of adverse reactions to haloperidol in a mouse diallel: a drug-placebo experiment and Bayesian causal analysis.Genetics of antipsychotic treatment emergent weight gain in schizophrenia.Sequence comparison of prefrontal cortical brain transcriptome from a tame and an aggressive silver fox (Vulpes vulpes).Serotonin and norepinephrine reuptake inhibition and eating behavior.Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence.Pharmacogenetics of antipsychotic-induced side effectsSalience network and olanzapine in schizophrenia: implications for treatment in anorexia nervosa.Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in miceNeural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment.Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targetsTardive dyskinesia and essential fatty acids.Serotonin2C Receptors and the Motor Control of Oral ActivityIndividualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics.Antipsychotic induced weight gain in schizophrenia:mechanisms and management.759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment.From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics.Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Atypical antipsychotic-induced weight gain: insights into mechanisms of action.Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.Individualizing clozapine and risperidone treatment for schizophrenia patients.Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action.A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?A novel translational assay of response inhibition and impulsivity: effects of prefrontal cortex lesions, drugs used in ADHD, and serotonin 2C receptor antagonism.Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study.The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX.BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.A pharmacogenomic study revealed an association between SLC6A4 and risperidone-induced weight gain in Chinese Han population.Differential serotonergic modulation across the main and accessory olfactory bulbs.RNA-Seq Analysis Reveals a Positive Role of HTR2A in Adipogenesis in Yan Yellow Cattle.Olanzapine: review of safety 2008The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study
P2860
Q24564963-81DB53F7-27D8-4092-8ED3-67FE6F9FE093Q24610124-752054D7-DE6C-4476-8C7B-8A49B12A9130Q24657338-7D848CB8-E2CA-4F80-B526-C4B633B2BE1DQ28475961-DB703ACE-9230-40EB-8F00-F6F6A4BD9B62Q30445406-A03C92B1-FDEF-4523-97A4-7CBDEBCCA460Q33257886-D3E88476-2BF8-403D-8C7F-778FF005B9B4Q34038575-0F7C59B0-8EDE-4714-9D8E-E75E4EAAB423Q34587982-7B5118C8-E76D-4164-95F6-64924EA2A613Q34625174-73925D7D-A932-4C8E-8348-8BEF26A5469EQ35237129-61818312-99FB-4F75-A6FB-180212821917Q35566102-69C38770-6584-4C07-A113-06FA5025172AQ35974641-0ED548F8-3CA4-4043-94AC-0579F5D3FB8BQ36061639-43F7EA2B-DC5D-4851-A1C4-B524AA53C918Q36316001-CFD7ABF9-009A-4624-AC38-949407A759E6Q36508056-F1C3E518-4CDC-44E4-A023-237AD51413C1Q36798864-4D5B5450-9DA5-41E1-8002-E9E88D15A258Q36946132-8F12853C-F370-41C1-B167-68426A9E1140Q37160453-415D0135-27FE-4376-A84D-DE6FB04F83F7Q37719385-90AF71FF-14EE-4765-803E-4B02ECA014C0Q37806982-B497AAD0-5622-4C7C-86FF-0DE8A206360AQ37865505-5B98FA59-93D8-421C-8262-161E082D60AAQ37926893-539143D2-FA78-4BD2-97C0-EABC5CFE1220Q37963571-4E187229-84F8-4BD9-99E2-F338FCB9DA72Q38101499-EE62B8A3-AD60-47D3-951B-26E0702B4888Q38170458-D22F1EB5-D9C3-4098-B442-A9B782B392C8Q38262202-CE23A35F-13C3-4118-8433-5D6478451EECQ39164871-E4ED9A31-83EC-4E03-98FD-684873FB738FQ41205365-78839468-B539-4148-874A-6E7963A9199EQ42618281-CB46EAAC-0956-4184-8D4B-C5B813C10742Q45252599-8514A70C-A195-4A03-83FF-027CDC8353E6Q46533539-A6294AAD-BEF4-4DCC-A45D-5FC59A23F861Q46911651-DB8EB2B2-D698-4B15-B6C7-421D417E537FQ47301630-A86C756F-1410-453E-A812-6CDAE1B26566Q47348196-0502414C-C98F-4DB1-BAD0-967A8E781046Q48204671-E9870873-B043-46A5-A6DB-90F598A3EF29Q55619198-FC174B2D-FF9C-43EC-8D87-D0C0DE8F126AQ56791028-21F523E8-97F3-4B4B-A892-F94F40498721Q57317087-F0501FA8-ECA7-4486-A976-3B75F77CDF1E
P2860
The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The role of 5-HT2C receptor po ...... f antipsychotic drug treatment
@ast
The role of 5-HT2C receptor po ...... f antipsychotic drug treatment
@en
The role of 5-HT2C receptor po ...... f antipsychotic drug treatment
@nl
type
label
The role of 5-HT2C receptor po ...... f antipsychotic drug treatment
@ast
The role of 5-HT2C receptor po ...... f antipsychotic drug treatment
@en
The role of 5-HT2C receptor po ...... f antipsychotic drug treatment
@nl
prefLabel
The role of 5-HT2C receptor po ...... f antipsychotic drug treatment
@ast
The role of 5-HT2C receptor po ...... f antipsychotic drug treatment
@en
The role of 5-HT2C receptor po ...... f antipsychotic drug treatment
@nl
P1476
The role of 5-HT2C receptor po ...... f antipsychotic drug treatment
@en
P2093
Lucy A Templeman
Zhi Jun Zhang
P304
P356
10.1016/J.PNPBP.2005.03.019
P407
P577
2005-07-01T00:00:00Z